Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

61.20 -0.58 (-0.93%)
Streaming Delayed Price Updated: 2:45 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference
From Hologic, Inc.
Via Business Wire
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
From Hologic, Inc.
Via Business Wire
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
From Hologic, Inc.
Via Business Wire
Hologic Completes Acquisition of Gynesonics, Inc.
From Hologic, Inc.
Via Business Wire
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
From Hologic, Inc.
Via Business Wire
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
From Hologic, Inc.
Via Business Wire
Martin Madaus Elected to Hologic Board of Directors
From Hologic, Inc.
Via Business Wire
New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence
From Hologic, Inc.
Via Business Wire
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
From Hologic, Inc.
Via Business Wire
Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
From Hologic, Inc.
Via Business Wire
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Third Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Hologic Completes Acquisition of Endomagnetics Ltd
From Hologic, Inc.
Via Business Wire
72 Million American Women Have Skipped or Delayed Vital Screenings
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
From Hologic, Inc.
Via Business Wire
Biotech Innovations Paving the Way in Breast Cancer Fight
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
Exposures Death Product Safety
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
From Hologic, Inc.
Via Business Wire
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
From Hologic, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.